NOACs Associated With Less Bleeding Vs. Warfarin In Afib With A Single Stroke Risk

June 26, 2017

Non–vitamin K antagonist oral anticoagulants (NOACs) seem to be associated with less bleeding than warfarin in patients with atrial fibrillation and a single ischemic stroke risk, researchers suggest.  “Such patients are underrepresented or not studied in clinical trials,” Dr. Gregory Lip of the University of Birmingham, UK told Reuters Health.  As reported online June 14 in JAMA Cardiology, there were no significant differences between NOACs and warfarin in reduction of ischemic stroke or systemic embolism, the principal effectiveness endpoint.